RESTON HOSPITAL
1. Target Overview & Investment Thesis
RESTON HOSPITAL is a 201-bed suburban community hospital in FAIRFAX, VA with $385.5M in net patient revenue and a 34.6% operating margin. The hospital serves a payer mix of 27.1% Medicare, 6.5% Medicaid, and 66.4% commercial.
Thesis: Platform Growth. Our ML models identify $28.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 34.6% to 42.0% (+736bps).
| Net Revenue HCRIS | $385.5M |
| Current EBITDA COMPUTED | $133.4M |
| Operating Margin COMPUTED | 34.6% |
| Occupancy HCRIS | 72.3% |
| Revenue / Bed COMPUTED | $1.9M |
| Net-to-Gross HCRIS | 20.4% |
| Distress Probability ML | 41.8% |
2. Market Context & Competitive Position
VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of 34.6% places it above the state median. Among 39 size-comparable peers (100-402 beds), the median margin is 5.2%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (100-402), prioritizing same-state peers. 39 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| RESTON HOSPITAL (Target) | VA | 201 | $385.5M | 34.6% |
| RIVERSIDE REGIONAL MEDICAL CEN | VA | 379 | $963.3M | -20.1% |
| ST. MARYS HOSPITAL | VA | 363 | $688.9M | 13.3% |
| VIRGINIA HOSPITAL CENTER ARLIN | VA | 336 | $624.4M | 1.8% |
| CHILDRENS HOSPITAL OF THE KING | VA | 202 | $546.2M | -9.9% |
| SENTARA LEIGH HOSPITAL | VA | 274 | $511.5M | 14.7% |
| INOVA LOUDOUN HOSPITAL CENTER | VA | 189 | $510.3M | 22.9% |
| INOVA ALEXANDRIA HOSPITAL | VA | 303 | $456.5M | 26.3% |
| SENTARA VA. BEACH GENERAL HOSP | VA | 239 | $443.9M | 15.2% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $28.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $8.1M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $7.7M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $7.6M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $4.7M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $247K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $133.4M |
| + RCM Uplift | +$28.4M |
| Pro Forma EBITDA | $161.8M |
| Current Margin | 34.6% |
| Pro Forma Margin | 42.0% |
| WC Released (1x) | $14.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $205.2M | $1.16B | 5.67x | 41.5% |
| Base (11x exit) | 10.0x | 11.0x | $205.2M | $1.35B | 6.56x | 45.7% |
| Bull Case | 9.0x | 11.0x | $184.7M | $1.51B | 8.16x | 52.2% |
| Bull (12x exit) | 9.0x | 12.0x | $184.7M | $1.70B | 9.20x | 55.9% |
| Bear Case | 11.0x | 10.0x | $225.7M | $955.0M | 4.23x | 33.4% |
| Bear (11x exit) | 11.0x | 11.0x | $225.7M | $1.12B | 4.98x | 37.9% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 39 hospitals with 100-402 beds
- Same-state prioritization (n=40)
- Comp margins: P25=-4.1% / P50=5.2% / P75=14.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.